title: [Purpura in patient with disseminated strongiloidiasis].
abstract: The association of systemic corticosteroid therapy and dissemination of Strongyloides stercoralis has been increasingly documented in the literature. Skin involvement in disseminated strongyloidiasis has been reported and the most commonly described cutaneous manifestations are rash and petechial eruptions. We present a case of an immunosuppressed man that developed disseminated strongyloidiasis with extensive purpura.
authors.affiliation: Núcleo de Estudos de Doenças Infecciosas e Tropicais de Mato Grosso, Cuiabá, MT. lucorrea@terra.com.br
authors.forename: Luciano C
authors.initials: LC
authors.lastname: Ribeiro
authors.forename: Edson N A
authors.initials: EN
authors.lastname: Rodrigues Junior
authors.forename: Margareth D
authors.initials: MD
authors.lastname: Silva
authors.forename: Arley
authors.initials: A
authors.lastname: Takiuchi
authors.forename: Cor Jesus F
authors.initials: CJ
authors.lastname: Fontes
mesh_terms: D000305:Adrenal Cortex Hormones / Q000627:therapeutic use; D000328:Adult; D000818:Animals; D000969:Antinematodal Agents / Q000627:therapeutic use; D006801:Humans; D016867:Immunocompromised Host; D008297:Male; D009157:Myasthenia Gravis / Q000188:drug therapy; D011693:Purpura / Q000469:parasitology* / Q000473:pathology; D017171:Strongyloides stercoralis; D013322:Strongyloidiasis / Q000150:complications* / Q000175:diagnosis / Q000188:drug therapy; D013827:Thiabendazole / Q000627:therapeutic use
chemical_list: D000305:Adrenal Cortex Hormones; D000969:Antinematodal Agents; D013827:Thiabendazole